2,432
Views
291
CrossRef citations to date
0
Altmetric
Review

Colorectal cancer development and advances in screening

Pages 967-976 | Published online: 19 Jul 2016

References

  • American Cancer SocietyColorectal Cancer Facts & Figures 2011–2013Atlanta, GAAmerican Cancer Society2011
  • American Cancer SocietyCancer Facts & Figures 2015Atlanta, GAAmerican Cancer Society2015
  • National Cancer Institute [webpage on the Internet]Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Colon and Rectum Cancer Available from: http://seer.cancer.gov/statfacts/html/colorect.htmlAccessed March 3, 2016
  • ACS [webpage on the Internet]What are the survival rates for colorectal cancer by stage?2015 Available from: http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-survival-rates; http://tinyurl.com/grroztxAccessed March 3, 2016
  • MariottoABYabroffKRShaoYFeuerEJBrownMLProjections of the cost of cancer care in the United States: 2010–2020J Natl Cancer Inst2011103211712821228314
  • Lansdorp-VogelaarIvan BallegooijenMZauberAGHabbemaJDKuipersEJEffect of rising chemotherapy costs on the cost savings of colorectal cancer screeningJ Natl Cancer Inst2009101301412142219779203
  • Centers for Disease Control and PreventionVital signs: colorectal cancer screening test use-United States, 2012MMWR Morb Mortal Wkly Rep2013624488188824196665
  • National Colorectal Cancer Roundtable [webpage on the Internet]. 80% by 2018 Available from: http://nccrt.org/tools/80-percent-by-2018/80-by-2018-press-kit/Accessed March 3, 2016
  • MeesterRGDoubeniCAZauberAGPublic health impact of achieving 80% colorectal cancer screening rates in the United States by 2018Cancer2015121132281228525763558
  • FrankSADynamics of Cancer: Incidence, Inheritance, and EvolutionPrinceton (NJ)Princeton University Press2007 Chapter 3, Multistage Progression. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1562/Accessed June 15, 2016
  • StracciFZorziMGrazziniGColorectal cancer screening: tests, strategies, and perspectivesFront Public Health2014221025386553
  • ConteducaVSansonnoDRussiSDammaccoFPrecancerous colorectal lesions (review)Int J Oncol201343497398423900573
  • YamaneLScapulatempo-NetoCReisRMGuimarãesDPSerrated pathway in colorectal carcinogenesisWorld J Gastroenterol201420102634264024627599
  • EastJEViethMRexDKSerrated lesions in colorectal cancer screening: detection, resection, pathology and surveillanceGut2015646991100025748647
  • SnoverDCUpdate on the serrated pathway to colorectal carcinomaHum Pathol201142111020869746
  • SiegelRLWardEMJemalATrends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992–2008Cancer Epidemiol Biomarkers Prev201221341141622219318
  • LochheadPChanATGiovannucciEProgress and opportunities in molecular pathological epidemiology of colorectal premalignant lesionsAm J Gastroenterol201410981205121424935274
  • NagyJAChangSHDvorakAMDvorakHFWhy are tumour blood vessels abnormal and why is it important to know?Br J Cancer2009100686586919240721
  • HeinenCDSchmutteCFishelRDNA repair and tumorigenesis: lessons from hereditary cancer syndromesCancer Biol Ther20021547748512496472
  • KinzlerKWVogelsteinBLessons from hereditary colorectal cancerCell19968721591708861899
  • BatemanACPathology of serrated colorectal lesionsJ Clin Pathol2014671086587424561317
  • PinoMSChungDCThe chromosomal instability pathway in colon cancerGastroenterology201013862059207220420946
  • KangGHFour molecular subtypes of colorectal cancer and their precursor lesionsArch Pathol Lab Med2011135669870321631262
  • KambaraTSimmsLAWhitehallVLBRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectumGut20045381137114415247181
  • LohKChiaJAGrecoSBone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer developmentGenes Chromosomes Cancer200847644946018311777
  • MelotteVLentjesMHvan den BoschSMN-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancerJ Natl Cancer Inst20091011391692719535783
  • BolandCRGoelAMicrosatellite instability in colorectal cancerGastroenterology201013862073.e32087.e320420947
  • O’BrienMJYangSMackCComparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end pointsAm J Surg Pathol200630121491150117122504
  • KoinumaKShitohKMiyakuraYMutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomasInt J Cancer2004108223724214639609
  • LingBSMoskowitzMAWachsDPearsonBSchroyPCAttitudes toward colorectal cancer screening testsJ Gen Intern Med2001161282283011903761
  • Agency for Healthcare Research and QualityClinical Summaries of Recommendations for Adults: Colorectal Cancer. Guide to Clinical Preventive ServicesRockville, MDAgency for Healthcare Research and Quality2014
  • RegulaJRupinskiMKraszewskaEColonoscopy in colorectal-cancer screening for detection of advanced neoplasiaN Engl J Med2006355181863187217079760
  • ImperialeTFWagnerDRLinCYLarkinGNRoggeJDRansohoffDFRisk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findingsN Engl J Med2000343316917410900275
  • LiebermanDAWeissDGBondJHAhnenDJGarewalHChejfecGUse of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380N Engl J Med2000343316216810900274
  • SchoenfeldPCashBFloodAColonoscopic screening of average-risk women for colorectal neoplasiaN Engl J Med2005352202061206815901859
  • CottonPBDurkalskiVLPineauBCComputed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasiaJAMA2004291141713171915082698
  • LiebermanDAHolubJEisenGKraemerDMorrisCDPrevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United StatesClin Gastroenterol Hepatol20053879880516234009
  • PickhardtPJChoiJRHwangIComputed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adultsN Engl J Med2003349232191220014657426
  • RockeyDCPaulsonENiedzwieckiDAnalysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparisonLancet2005365945630531115664225
  • BaxterNNGoldwasserMAPaszatLFSaskinRUrbachDRRabeneckLAssociation of colonoscopy and death from colorectal cancerAnn Intern Med200915011819075198
  • MüllerADSonnenbergAPrevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veteransAnn Intern Med1995123129049107486484
  • SinghHTurnerDXueLTargownikLEBernsteinCNRisk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopiesJAMA2006295202366237316720822
  • LevinBLiebermanDAMcFarlandBScreening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyGastroenterology200813451570159518384785
  • WexnerSDBeckDEBaronTHA consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)Gastrointest Endosc200663789490916733101
  • CooperGSKouTDRexDKComplications following colonoscopy with anesthesia assistance: a population-based analysisJAMA Intern Med2013173755155623478904
  • InadomiJMVijanSJanzNKAdherence to colorectal cancer screening: a randomized clinical trial of competing strategiesArch Intern Med2012172757558222493463
  • SoetiknoRMKaltenbachTRouseRVPrevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adultsJAMA200829991027103518319413
  • CorleyDAJensenCDMarksARAdenoma detection rate and risk of colorectal cancer and deathN Engl J Med2014370261298130624693890
  • PatelSGAhnenDJPrevention of interval colorectal cancers: what every clinician needs to knowClin Gastroenterol Hepatol201412171523639602
  • SamadderNJCurtinKTuohyTMCharacteristics of missed or interval colorectal cancer and patient survival: a population-based studyGastroenterology2014146495096024417818
  • SelbyJVFriedmanGDQuesenberryCPJrWeissNSA case-control study of screening sigmoidoscopy and mortality from colorectal cancerN Engl J Med1992326106536571736103
  • HoffGGrotmolTSkovlundEBretthauerMNorwegian Colorectal Cancer Prevention Study GroupRisk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trialBMJ2009338b184619483252
  • BinefaGRodríguez-MorantaFTeuleAMedina-HayasMColorectal cancer: from prevention to personalized medicineWorld J Gastroenterol201420226786680824944469
  • JohnsonCDChenMHToledanoAYAccuracy of CT colonography for detection of large adenomas and cancersN Engl J Med2008359121207121718799557
  • U.S. Preventive Services Task ForceScreening for colorectal cancer: U.S. Preventive Services Task Force recommendation statementAnn Intern Med2008149962763718838716
  • WhitlockEPLinJSLilesEBeilTLFuRScreening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task ForceAnn Intern Med2008149963865818838718
  • SaliLMascalchiMFalchiniMSAVE Study InvestigatorsReduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of colorectal cancer: a randomized trialJ Natl Cancer Inst20161082
  • StoopEMde HaanMCde WijkersloothTRParticipation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trialLancet Oncol2012131556422088831
  • ASGE Technology CommitteeFarrayeFAAdlerDGUpdate on CT colonographyGastrointest Endosc2009693 Pt 139339819231482
  • Centers for Medicare and Medicaid ServicesDecision Memo for Screening Computed Tomography Colonography (CTC) for Colorectal Cancer (CAG-00396N)Baltimore, MDCenters for Medicare and Medicaid Services2009
  • de HaanMCPickhardtPJStokerJCT colonography: accuracy, acceptance, safety and position in organised population screeningGut201564234235025468258
  • LiebermanDAClinical practice. Screening for colorectal cancerN Engl J Med2009361121179118719759380
  • Canadian Agency for Drugs and Technologies in HealthFecal immunochemical tests for colorectal cancer screening: a systematic reviewCADTH Technol Overv201013e011722977407
  • de WijkersloothTRStoopEMBossuytPMImmunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasiaAm J Gastroenterol2012107101570157822850431
  • ImperialeTFRansohoffDFItzkowitzSHMultitarget stool DNA testing for colorectal-cancer screeningN Engl J Med2014370141287129724645800
  • LeeJKLilesEGBentSLevinTRCorleyDAAccuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysisAnn Intern Med2014160317124658694
  • ImperialeTFRansohoffDFItzkowitzSHTurnbullBARossMEColorectal Cancer Study GroupFecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk populationN Engl J Med2004351262704271415616205
  • AhlquistDASargentDJLoprinziCLStool DNA and occult blood testing for screen detection of colorectal neoplasiaAnn Intern Med20081497441450W8118838724
  • KronborgOFengerCOlsenJJørgensenODSøndergaardORandomised study of screening for colorectal cancer with faecal-occult-blood testLancet19963489040146714718942774
  • MandelJSBondJHChurchTRReducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control StudyN Engl J Med199332819136513718474513
  • HardcastleJDChamberlainJORobinsonMHRandomised controlled trial of faecal-occult-blood screening for colorectal cancerLancet19963489040147214778942775
  • YoungGPSymondsELAllisonJEAdvances in fecal occult blood tests: the FIT revolutionDig Dis Sci201560360962225492500
  • GelladZFStechuchakKMFisherDALongitudinal adherence to fecal occult blood testing impacts colorectal cancer screening qualityAm J Gastroenterol201110661125113421304501
  • LiangPSWheatCLAbhatAAdherence to competing strategies for colorectal cancer screening over 3 yearsAm J Gastroenterol2016111110511426526080
  • JensenCDCorleyDAQuinnVPFecal immunochemical test program performance over 4 rounds of annual screening: a retrospective cohort studyAnn Intern Med2016164745646326811150
  • SteeleRJMcDonaldPJDigbyJClinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacityUnited European Gastroenterol J201313198205
  • KapidzicAGrobbeeEJHolLAttendance and yield over three rounds of population-based fecal immunochemical test screeningAm J Gastroenterol201410981257126424980879
  • RedwoodDGAsayEDBlakeIDStool DNA testing for screening detection of colorectal Neoplasia in Alaska native peopleMayo Clin Proc2016911617026520415
  • American Cancer SocietyColorectal Cancer Prevention and Early DetectionAtlanta, GAAmerican Cancer Society2016
  • BergerBMSchroyPC3rdRosenbergJLColorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal testsClin Colorectal Cancer20065533834316512992
  • BergerBMSchroyPC3rdDinhTScreening for colorectal cancer using a multitarget stool DNA test: modeling the impact of the inter-test interval on clinical effectivenessClin Colorectal Cancer Epub2015121810.1016/j.clcc.2015.12.003
  • BergerBMPartonMALevinBUSPSTF CRC screening guidelines: an extended look at multi-year interval testingAm J Manag Care2016222e77e8126881323